42 filings · most recent first
ILMN 8-K Filings
Illumina Reports Q2 2026 Financial Results And Updates Guidance
Illumina Appoints Dr Daniel Skovronsky To Board Of Directors
Illumina Inc Announces Results Of 2026 Annual Meeting Of Stockholders
Illumina Announces Strong Q1 2026 Financial Results And New Share Repurchase
Illumina Nominates David P King To Board Of Directors
Illumina Reports Q4 And Fy 2025 Financial Results
Illumina Completes Acquisition Of Somalogic To Expand Proteomics Capabilities
Illumina Announces Preliminary Financial Results For Q4 And Fy 2025
Illumina Appoints New Chief Medical Officer And Announces Departure Of Chief
Illumina Completes 500M Notes Offering
Illumina Announces 500 Million Notes Issuance
Illumina Announces Acquisition Of Somalogic
Illumina Inc Terminates Credit Agreement And Issues New Notes
Illumina Announces 500 Million Note Offering
Illumina Completes Grail Spinoff
Illumina Announces New Credit Agreement
Illumina Announces Spinoff Distribution Dates For Grail Shares
Illumina Announces Spinoff Of Grail And Associated Costs
Illumina Reports Q3 2025 Financial Results And Updates Guidance
Illumina Reports Q2 2025 Financial Results And Provides Updated Fiscal Year
Illumina Inc Annual Meeting Results
Illumina Inc Announces First Quarter 2025 Financial Results
Illumina Appoints New Board Chair And Director Director Resignation
Illumina Inc Announces Retirement Of Chief Information Officer
Illumina Announces Fiscal Year 2025 Guidance And Cost Reductions Amid China
Illumina Reports Q4 And Fy 2024 Financial Results
Illumina Inc Announces Further Real Estate Impairment Charges
Illumina Announces Preliminary Financial Results For Q4 And Fy 2024
Illumina Reports Third Quarter 2024 Financial Results
Illumina Announces Q2 2024 Financial Results And Lowered Fy 2024 Guidance
Illumina Inc Announces 19 Billion Impairment Charge For Grail Spinoff
Illumina Completes Spinoff Of Grail And Releases Pro Forma Financials
Illumina Inc Announces Stockholder Approvals At 2024 Annual Meeting
Illumina Inc Records 75 Million In Impairment Charges Due To Facility Exit
Illumina Reports First Quarter 2024 Financial Results
Illumina Announces Ec Approval Of Grail Divestment Plan
Illumina Announces Q4 And Fy 2023 Financial Results With Goodwill Impairment
Illumina Inc Announces Estimated Impairment Charges Of 43M Related To Foster
Illumina Announces Preliminary Financial Results For Q4 And Fy 2023
Illumina Announces Departure Of General Counsel And Secretary
Illumina Announces New Cfo And Strategic Officer Appointments
Illumina Appoints Interim Chief Commercial Officer Following Departure Of Susan